"The U.S. Food and Drug Administration today approved Tivicay (dolutegravir), a new drug to treat HIV-1 infection.
Tivicay is an integrase strand transfer inhibitor that interferes with one of the enzymes necessary for HIV to multiply. "...
Selzentry Patient Information including If I Miss a Dose
In this Article
- What is maraviroc (Selzentry)?
- What are the possible side effects of maraviroc (Selzentry)?
- What is the most important information I should know about maraviroc (Selzentry)?
- What should I discuss with my health care provider before taking maraviroc (Selzentry)?
- How should I take maraviroc (Selzentry)?
- What happens if I miss a dose (Selzentry)?
- What happens if I overdose (Selzentry)?
- What should I avoid while taking maraviroc (Selzentry)?
- What other drugs will affect maraviroc (Selzentry)?
- Where can I get more information?
What happens if I miss a dose (Selzentry)?
Take the missed dose as soon as you remember. If you are more than 6 hours late in taking your maraviroc, skip the missed dose and take the next regularly scheduled dose. Do not take extra medicine to make up the missed dose.
What happens if I overdose (Selzentry)?
Seek emergency medical attention or call the Poison Help line at 1-800-222-1222.
Overdose symptoms may include feeling like you might pass out.
What should I avoid while taking maraviroc (Selzentry)?
Maraviroc may impair your thinking or reactions. Be careful if you drive or do anything that requires you to be alert.
Taking this medication will not prevent you from passing HIV to other people. Avoid having unprotected sex or sharing razors or toothbrushes. Talk with your doctor about safe ways to prevent HIV transmission during sex. Sharing drug or medicine needles is never safe, even for a healthy person.
What other drugs will affect maraviroc (Selzentry)?
You should not take maraviroc if you have severe kidney disease and you are also using certain drugs. Tell your doctor about all other medications you use.
Many drugs can interact with maraviroc. Below is just a partial list. Tell your doctor if you are using:
- conivaptan (Vaprisol);
- imatinib (Gleevec);
- isoniazid (for treating tuberculosis);
- rifampin (Rifadin, Rimactane, Rifater);
- St. John's wort;
- seizure medication such as carbamazepine (Carbatrol, Tegretol), phenobarbital (Solfoton), or phenytoin (Dilantin);
- an antibiotic such as clarithromycin (Biaxin), dalfopristin/quinupristin (Synercid), erythromycin (E.E.S., EryPed, Ery-Tab, Erythrocin), or telithromycin (Ketek);
- antifungal medication such as clotrimazole (Mycelex Troche), itraconazole (Sporanox), ketoconazole (Extina, Ketozole, Nizoral, Xolegal), or voriconazole (Vfend);
- heart or blood pressure medication such as diltiazem (Cartia, Cardizem), felodipine (Plendil), nifedipine (Nifedical, Procardia), verapamil (Calan, Covera, Isoptin, Verelan), and others; or
- HIV/AIDS medicine such as atazanavir (Reyataz), delavirdine (Rescriptor), didanosine (Videx), efavirenz (Sustiva), emtricitabine (Emtriva), enfuvirtide (Fuzeon), fosamprenavir (Lexiva), indinavir (Crixivan), lamivudine (Epivir, Combivir, Trizivir), nelfinavir (Viracept), nevirapine (Viramune), ritonavir (Norvir), saquinavir (Invirase), stavudine (Zerit), tipranavir (Aptivus), zalcitabine (Hivid), zidovudine (Retrovir).
Where can I get more information?
Your pharmacist can provide more information about maraviroc.
Remember, keep this and all other medicines out of the reach of children, never share your medicines with others, and use this medication only for the indication prescribed.
Every effort has been made to ensure that the information provided by Cerner Multum, Inc. ('Multum') is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Multum information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Multum does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Multum's drug information does not endorse drugs, diagnose patients or recommend therapy. Multum's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Multum does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 1996-2012 Cerner Multum, Inc. Version: 3.02. Revision date: 12/15/2010.
Your use of the content provided in this service indicates that you have read,understood and agree to the End-User License Agreement,which can be accessed by clicking on this link.
Additional Selzentry Information
- Selzentry Drug Interactions Center: maraviroc oral
- Selzentry Side Effects Center
- Selzentry Overview including Precautions
- Selzentry FDA Approved Prescribing Information including Dosage
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Get breaking medical news.